First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Hits New 12-Month High – Should You Buy?

Shares of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBTGet Free Report) reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as GBX 1,903 and last traded at GBX 1,903, with a volume of 7043 shares changing hands. The stock had previously closed at GBX 1,863.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Up 2.1%

The stock has a 50-day moving average of GBX 1,720.88 and a 200 day moving average of GBX 1,578.36. The company has a market capitalization of £780.64 million and a PE ratio of -1,730.00.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile

(Get Free Report)

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.

Further Reading

Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.